Maxim initiated coverage of Belite Bio with a Buy rating and $60 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BLTE:
- Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
- Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results
- Belite Bio reports Q3 EPS (40c), consensus (32c)
- Is BLTE a Buy, Before Earnings?
- Belite Bio participates in a conference call with Cantor Fitzgerald